PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials

Overview

Journal Cartilage

Date 2020 Jun 20

PMID 32551947

Citations 95

Authors

Giuseppe Filardo

Davide Previtali

Francesca Napoli

Christian Candrian

Stefano Zaffagnini

Alberto Grassi

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate effectiveness, in terms of patient-reported outcome measures, of platelet-rich plasma (PRP) injections for knee osteoarthritis compared to placebo and other intraarticular treatments.

Design: PubMed, Cochrane Library, Scopus, Embase, Web of Science, as well as the gray literature were searched on January 17, 2020. Randomized controlled trials (RCTs) comparing PRP injections with placebo or other injectable treatments, in any language, on humans, were included. Risk of bias was assessed following the Cochrane guidelines; quality of evidence was graded using the GRADE guidelines.

Results: Thirty-four RCTs, including 1403 knees in PRP groups and 1426 in control groups, were selected. WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score favored PRP, with a statistically and clinically significant difference versus placebo at 12-month follow-up ( = 0.02) and versus HA (hyaluronic acid) at 6-month ( < 0.001) and 12-month ( < 0.001) follow-ups. A clinically significant difference favoring PRP versus steroids was documented for VAS (Visual Analogue Scale) pain ( < 0.001), KOOS (Knee Injury and Osteoarthritis Outcome Score) pain ( < 0.001), function in daily activities ( = 0.001), and quality of life ( < 0.001) at 6-month follow-up. However, superiority of PRP did not reach the minimal clinically important difference for all outcomes, and quality of evidence was low.

Conclusions: The effect of platelet concentrates goes beyond its mere placebo effect, and PRP injections provide better results than other injectable options. This benefit increases over time, being not significant at earlier follow-ups but becoming clinically significant after 6 to 12 months. However, although substantial, the improvement remains partial and supported by low level of evidence. This finding urges further research to confirm benefits and identify the best formulation and indications for PRP injections in knee OA.

Citing Articles

Blood flow restriction-enhanced platelet-rich plasma: A pilot randomised controlled trial protocol.

Ayyan M, Alladaboina S, Al-Dolaymi A, Boudier-Reveret M, Papakostas E, Marin Fermin T J Exp Orthop. 2025; 12(1):e70034.

PMID: 39822661 PMC: 11735946. DOI: 10.1002/jeo2.70034.

PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials.

Bensa A, Previtali D, Sangiorgio A, Boffa A, Salerno M, Filardo G Am J Sports Med. 2025; 53(3):745-754.

PMID: 39751394 PMC: 11874499. DOI: 10.1177/03635465241246524.

Comparing the efficacy of intra-articular injection of Platelet Rich Plasma (PRP) with corticosteroids (CS) in patients with chronic zygapophyseal joint low back pain confirmed by double intra-articular diagnostic blocks: A triple-blinded randomized....

Cauchon A, Mares C, Fan X, Bois M, Hagemeister N, Noiseux N Interv Pain Med. 2024; 3(4):100525.

PMID: 39717452 PMC: 11665351. DOI: 10.1016/j.inpm.2024.100525.

Bone Marrow Aspirate Concentrate Injections for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials.

Han J, Jung M, Chung K, Jung S, Choi C, Kim S Orthop J Sports Med. 2024; 12(12):23259671241296555.

PMID: 39640186 PMC: 11618931. DOI: 10.1177/23259671241296555.

Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).

Eymard F, Oubaya N, Ornetti P, Sellam J, Richette P, Chevalier X BMJ Open. 2024; 14(11):e085025.

PMID: 39615889 PMC: 11624835. DOI: 10.1136/bmjopen-2024-085025.

References

Lee H, Park K, Joung Y, Park K, Do S . Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release. 2012; 159(3):332-7. DOI: 10.1016/j.jconrel.2012.02.008. View

Raeissadat S, Rayegani S, Hassanabadi H, Fathi M, Ghorbani E, Babaee M . Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) Versus Hyaluronic Acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015; 8:1-8. PMC: 4287055. DOI: 10.4137/CMAMD.S17894. View

Uslu Guvendi E, Askin A, Guvendi G, Kocyigit H . Comparison of Efficiency Between Corticosteroid and Platelet Rich Plasma Injection Therapies in Patients With Knee Osteoarthritis. Arch Rheumatol. 2019; 33(3):273-281. PMC: 6328223. DOI: 10.5606/ArchRheumatol.2018.6608. View

Raeissadat S, Rayegani S, Gharooee Ahangar A, Abadi P, Mojgani P, Gharooi Ahangar O . Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial. Clin Med Insights Arthritis Musculoskelet Disord. 2017; 10:1179544117733452. PMC: 5638152. DOI: 10.1177/1179544117733452. View

Harrison P . The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost. 2018; 16(9):1895-1900. DOI: 10.1111/jth.14223. View

Smith P . Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial. Am J Sports Med. 2016; 44(4):884-91. DOI: 10.1177/0363546515624678. View

Gormeli G, Gormeli C, Ataoglu B, Colak C, Aslanturk O, Ertem K . Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2015; 25(3):958-965. DOI: 10.1007/s00167-015-3705-6. View

Angst F, Aeschlimann A, Stucki G . Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the.... Arthritis Rheum. 2001; 45(4):384-91. DOI: 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0. View

Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A . Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?. Biomed Res Int. 2014; 2014:692913. PMC: 4124719. DOI: 10.1155/2014/692913. View

10.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

11.

Previtali D, Merli G, di Laura Frattura G, Candrian C, Zaffagnini S, Filardo G . The Long-Lasting Effects of "Placebo Injections" in Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2020; 13(1_suppl):185S-196S. PMC: 8808779. DOI: 10.1177/1947603520906597. View

12.

Saltzman B, Leroux T, Meyer M, Basques B, Chahal J, Bach Jr B . The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies. Am J Sports Med. 2016; 45(11):2647-2653. DOI: 10.1177/0363546516680607. View

13.

Elik H, Dogu B, Yilmaz F, Akan Begoglu F, Kuran B . The efficiency of platelet-rich plasma treatment in patients with knee osteoarthritis. J Back Musculoskelet Rehabil. 2019; 33(1):127-138. DOI: 10.3233/BMR-181374. View

14.

Buendia-Lopez D, Medina-Quiros M, Fernandez-Villacanas Marin M . Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial. J Orthop Traumatol. 2018; 19(1):3. PMC: 6102156. DOI: 10.1186/s10195-018-0501-3. View

15.

Pas H, Winters M, Haisma H, Koenis M, Tol J, Moen M . Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med. 2017; 51(15):1125-1133. DOI: 10.1136/bjsports-2016-096793. View

16.

Ahmad H, Farrag S, Okasha A, Kadry A, Ata T, Monir A . Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis. Int J Rheum Dis. 2018; 21(5):960-966. DOI: 10.1111/1756-185X.13315. View

17.

Johnston B, Thorlund K, da Costa B, Furukawa T, Guyatt G . New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures. J Clin Epidemiol. 2012; 65(8):817-26. DOI: 10.1016/j.jclinepi.2012.02.008. View

18.

Forogh B, Mianehsaz E, Shoaee S, Ahadi T, Raissi G, Sajadi S . Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness. 2015; 56(7-8):901-8. View

19.

Cerza F, Carni S, Alessandro Carcangiu , Di Vavo I, Schiavilla V, Pecora A . Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012; 40(12):2822-7. DOI: 10.1177/0363546512461902. View

20.

Khatab S, van Buul G, Kops N, Bastiaansen-Jenniskens Y, Bos P, Verhaar J . Intra-articular Injections of Platelet-Rich Plasma Releasate Reduce Pain and Synovial Inflammation in a Mouse Model of Osteoarthritis. Am J Sports Med. 2018; 46(4):977-986. DOI: 10.1177/0363546517750635. View